Earnings History Data for Marker Therapeutics, Inc. (MRKR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
22-03-2023 ?? Before the open
(Mar 22)
MRKR Marker Therapeutics, Inc. 18.79 N/A 0.00 -1.20 Marker Therapeutics GAAP EPS of -$3.58 beats by $0.02, revenue of $9.01M beats by $0.01M
[3/22/2023 8:45 AM]
0.9398 -0.26 
(-21.68%)
1.20 0.0 
(0.00%)
0.88 - 5.20 343,386 60,000 1,584
11-08-2022 AH After the close
(Aug 11)
MRKR MARKER THERAPEUTICS 43.00 -0.11 -0.13 0.00 Marker Therapeutics GAAP EPS of -$0.11 misses by $0.01, revenue of $0.79M misses by $1.71M
[8/11/2022 5:03 PM]
0.3963 -0.05 
(-11.64%)
0.45 0.0 
(0.33%)
0.25 - 2.05 929,285 9,690,000 15,284
13-05-2022 PM Before the open
(May 13)
MRKR MARKER THERAPEUTICS 26.00 -0.12 -0.13 0.00 Marker Therapeutics GAAP EPS of -$0.12 beats by $0.01, revenue of $964.32M
[5/13/2022 7:48 AM]
0.3270 0.01 
(4.14%)
0.31 0.0 
(-1.27%)
0.28 - 3.65 478,383 260,000 447
17-03-2022 AH MRKR MARKER THERAPEUTICS 33.00 -0.12 -0.12 0.00 Marker Therapeutics GAAP EPS of -$0.55 beats by $0.02, revenue of $1.24M
[3/17/2022 6:05 PM]
0.4348 0.0 
(0.79%)
0.4411 0.01 
(2.25%)
0.35 - 3.65 458,357 740,077 11,001
10-11-2021 AH MRKR MARKER THERAPEUTICS 125.00 -0.12 -0.13 0.00 Marker Therapeutics EPS misses by $0.02
[11/10/2021 4:38 PM]
1.42 -0.05 
(-3.40%)
1.47 0.0 
(0.00%)
1.38 - 3.77 397,450 250,000 1,001
10-08-2021 AH 4:05 PM ET
(Aug 10)
MRKR Marker Therapeutics, Inc. 173.50 -0.13 -0.12 -0.14 Marker Therapeutics EPS misses by $0.01
[8/10/2021 5:14 PM]
1.98 -0.03 
(-1.74%)
2.00 -0.01 
(-0.50%)
1.32 - 3.77 682,787 300,000 5,425
12-05-2021 AH 4:10 PM ET
(May 12)
MRKR Marker Therapeutics, Inc. 195.08 -0.16 -0.16 -0.14 Marker Therapeutics EPS misses by $0.02
[5/12/2021 4:22 PM]
2.11 -0.05 
(-2.55%)
2.22 0.06 
(2.78%)
1.32 - 3.77 3,144,505 1,680,000 7,477
09-03-2021 AH 4:00 PM ET
(Mar 9)
MRKR Marker Therapeutics, Inc. 109.00 -0.18 -0.16 0.00 Marker Therapeutics EPS misses by $0.02, misses on revenue
[3/9/2021 4:27 PM]
2.49 -0.02 
(-0.80%)
2.55 0.04 
(1.59%)
1.32 - 3.77 182,981 335,821 12,051
09-11-2020 AH 4:00 PM ET
(Nov 9)
MRKR Marker Therapeutics, Inc. 66.20 -0.16 -0.15 -0.12 Marker Therapeutics EPS misses by $0.02
[11/9/2020 4:29 PM]
1.48 0.0 
(-0.34%)
1.50 0.01 
(0.67%)
1.32 - 4.08 176,128 173,772 1,618